http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#Head http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#assertion http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#provenance http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#pubinfo http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#assertion http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object https://identifiers.org/MONDO:0021668 http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/CHEBI:119915 http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association http://www.w3.org/2000/01/rdf-schema#label ABSTRAL® is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving, and who are tolerant to, around-the-clock opioid therapy for their underlying persistent cancer pain. http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association https://w3id.org/biolink/vocab/has_population_context http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#cohort http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association https://w3id.org/biolink/vocab/provided_by NeuroDKG http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association https://w3id.org/biolink/vocab/publications https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e60f00e9-2cf4-4c20-b570-1c2ea426c8c7 http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#cohort http://www.w3.org/2000/01/rdf-schema#label cancer patients 18 years of age and older who are already receiving, and who are tolerant to, around-the-clock opioid therapy for their underlying persistent cancer pain http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#cohort https://schema.org/requiredMinAge 18 http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#cohort https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Cohort http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#cohort https://w3id.org/biolink/vocab/has_phenotype https://identifiers.org/MONDO:0005070 https://identifiers.org/CHEBI:119915 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug https://identifiers.org/MONDO:0021668 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#provenance http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#pubinfo http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#sig http://purl.org/nanopub/x/hasSignature KDxCEQgTVz+3euJPPQludpB26SPYwtqnb9Pqdch5GxDKyoM9wvVJbvhwJJn/jHp9gRg+gT0fajxiAbb63rxwLykXoYS1dn3JWjtv8eQsIQpSiSEqmIDwTZSo/oTUe0g0iiPVnpkiBILk1DfnTEBATLraqgmK1FNZ3bct77uveM4= http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c http://purl.org/dc/terms/created 2021-03-28T20:19:13.984+02:00 http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAoZURvqojuDxHzi2pYj0xmhs2oTGERwhNVcU12hxW49c https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RA59AEpaWRaR9sjdA0-n4zaQWdiZ6--iGafMrjrDAOheI